PATENT CLAIM ANALYSIS

Application Number: 15921354
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "017700"]

Abstract:
Methods and compositions used in treating traumatic brain injury using a recombinant DRα-MOG-35-55 construct are disclosed. The disclosed methods involve administering a pharmaceutical composition comprising DRα-MOG-35-55 and a pharmaceutically acceptable carrier to a subject that has had a traumatic brain injury.

Claim (Index 5):
The method of  claim 1  wherein the composition comprises a dose of 1-100 mg/kg of DR\u03b11-MOG-35-55.

Metadata:
- Claim Count in Document: 33.0
- Percentile: 90.0
- Lexical Diversity: 1.34375
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14613658', '11661777', '13096423', '14823637', '15136160']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7647570635081695
- 35 USC 102 Novelty (BERT): 0.5130644496380232
- Combined Prediction Score: 0.7395878021211549
- Mean Citation Score: 213.070226
- Max Citation Score: 227.7852
- Similarity Product: 129.9759533018589

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test